drugset / Trial / NCT00429702

Diphenhydramine, Lorazepam, and Dexamethasone in Treating Nausea and Vomiting Caused By Chemotherapy

NCT00429702 ↗

RandomizedParallel-groupTriple-blindSupportive care

Summary

RATIONALE: Diphenhydramine, lorazepam, and dexamethasone may help lessen or prevent nausea and vomiting in patients treated with chemotherapy. It is not yet known whether diphenhydramine, lorazepam, and dexamethasone are more effective than standard therapy in treating nausea and vomiting caused by chemotherapy. PURPOSE: This randomized phase II trial is studying diphenhydramine, lorazepam, and dexamethasone to see how well they work compared with standard therapy in treating nausea and vomiting caused by chemotherapy in young patients with newly diagnosed cancer.

Timeline

Start
2007-10
Primary completion
2009-08
Completion
2009-11

Outcome

Outcome not reported

Stopped (Enrollment): “Closed due to poor accrual and lack of feasibility to finish study per DSMB”

Drugs

EvaluationDrugModalityDoseRoute
Subject Dexamethasone Small molecule — Intravenous
Subject Diphenhydramine Small molecule — Intravenous
Subject Lorazepam Small molecule — Intravenous
Background Ondansetron Other / unclassified — Intravenous